About Centro Hemato Oncologico Paitilla
"25 años "Contigo en cada paso" Contamos con especialistas en cáncer y enfermedades de la sangre. Centro Medico Especializado en: Consulta Externa Interconsultas a pacientes hospitalizados Manejo integral del cancer y de las enfermedades de la sangre (Anemias) Aplicación de quimioterapia ambulatoria Cuidados paliativos y control crónico Manejo y cuidado de catèteres venosos centrales Factores de crecimiento hematopoyético Procedimiento de aspirado de médula òsea, biopsia de hueso Transfusión de sangre y sus derivados Apoyo a nuestros pacientes en el cuidado, orientación y sus tratamientos."
Clinical Trials at Centro Hemato Oncologico Paitilla
During the past decade, Centro Hemato Oncologico Paitilla conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Hemato Oncologico Paitilla"
#1 collaborator was "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Centro Hemato Oncologico Paitilla
According to Clinical.Site data, the most researched conditions in "Centro Hemato Oncologico Paitilla" are
"B-cell Lymphoma" (1 trials), "Breast Cancer" (1 trials) and "Gastric Cancer" (1 trials). Many other conditions were trialed in "Centro Hemato Oncologico Paitilla" in a lesser frequency.
Clinical Trials Intervention Types at Centro Hemato Oncologico Paitilla
Most popular intervention types in "Centro Hemato Oncologico Paitilla" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "trastuzumab emtansine" (2 trials), "Bevacizumab" (1 trials), "CHOP" (1 trials), "Placebo" (1 trials) and "Rituximab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centro Hemato Oncologico Paitilla
The vast majority of trials in "Centro Hemato Oncologico Paitilla" are
3 trials for "All" genders.
Clinical Trials Status at Centro Hemato Oncologico Paitilla
Currently, there are NaN active trials in "Centro Hemato Oncologico Paitilla".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Centro Hemato Oncologico Paitilla,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Centro Hemato Oncologico Paitilla, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".